查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1542594

全球红色生物技术市场研究报告 - 2024年至2032年行业分析、规模、份额、成长、趋势和预测

Global Red Biotechnology Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 129 Pages | 商品交期: 最快1-2个工作天内

价格

全球红色生物技术市场需求预计将从2023年的6,047.2亿美元达到近1,5,393.9亿美元的市场规模，2024-2032年研究期间复合年增长率为10.94%。

红色生物技术，也称为医疗生物技术，是生物技术的一个分支，专注于药品、医疗器材、诊断和医疗保健解决方案。与绿色生物技术（农业生物技术）和白色生物技术（工业生物技术）不同，它主要针对医疗和保健应用。它涉及使用生物过程、有机体或系统来开发产品和技术来诊断、预防和治疗疾病并改善整体医疗保健结果。

市场动态

在全球慢性病和传染病患者病率上升的推动下，全球红色生物技术市场正在显着成长。红色生物技术对于开发创新疗法、疫苗和诊断工具至关重要，以应对与癌症、糖尿病、心血管疾病和 COVID-19 等传染病相关的医疗保健挑战。此外，基因组研究、个人化医疗和生物製药的进步正在推动市场成长。基因编辑、重组 DNA 技术和单株抗体等技术可实现针对性和客製化的医疗保健方法，从而提高治疗效果和患者预后。

此外，製药公司、学术机构和政府组织对研发（R&D）的投资不断增加，推动了红色生物技术的创新。这些投资支持发现新的候选药物、疾病诊断的生物标记以及利用生物技术进步的突破性疗法。学术界、工业界和医疗保健提供者之间的合作促进跨学科研究工作，将科学发现转化为临床应用。然而，生物製药和医疗创新带来的高成本和漫长的开发时间、监管挑战和生物技术产品严格的审批流程对市场成长构成了挑战。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对红色生物技术全球市场的各个细分市场进行了包容性评估。红色生物技术产业的成长和趋势为本研究提供了整体方法。

市场区隔

红色生物技术市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略家确定相应产品或服务的目标人口统计数据以及即将到来的机会。

按产品分类

  • 单株抗体
  • 多株抗体抗体
  • 重组蛋白
  • 疫苗
  • 基于细胞的免疫疗法产品
  • 基因治疗产品
  • 细胞治疗产品
  • 组织工程产品
  • 干细胞
  • 细胞培养
  • 病毒载体
  • 酵素
  • 试剂盒和试剂
  • 动物模型
  • 分子诊断
  • 其他的

按最终用户

  • 学术研究机构
  • CMO 和 CRO
  • 製药与生物技术公司
  • 其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲红色生物技术市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。红色生物技术市场的主要参与者包括默克公司、罗氏公司、辉瑞公司、再生元製药公司、阿斯特捷利康公司、武田製药有限公司、吉利德科学公司、百健公司、安进公司、新基公司。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：红色生物技术 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按产品分類的市场吸引力分析
    • 最终用户的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球红色生物技术市场分析：依产品分类

  • 概述（按产品）
  • 按产品分类的历史和预测资料分析
  • 单株抗体
  • 多株抗体抗体
  • 重组蛋白
  • 疫苗
  • 基于细胞的免疫疗法产品
  • 基因治疗产品
  • 细胞治疗产品
  • 组织工程产品
  • 干细胞
  • 细胞培养
  • 病毒载体
  • 酵素
  • 试剂盒和试剂
  • 动物模型
  • 分子诊断
  • 其他的

第 6 章：全球红色生物技术市场分析：依最终用户分类

  • 最终用户概述
  • 最终用户的历史和预测数据分析
  • 学术研究机构
  • CMO 和 CRO
  • 製药与生物技术公司
  • 其他的

第 7 章：全球红色生物技术市场分析：依地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区按国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲按国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第8章：红色生物科技公司的竞争格局

  • 红色生物科技市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 9 章：公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Merck KGaA
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • F. Hoffmann-La Roche AG
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Pfizer Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Regeneron Pharmaceuticals Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • AstraZeneca Plc
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Takeda Pharmaceutical Company Limited
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Gilead Sciences
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Biogen Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Amgen Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Celgene Corporation
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

Product Code: VMR11219534

The global demand for Red Biotechnology Market is presumed to reach the market size of nearly USD 1539.39 Billion by 2032 from USD 604.72 Billion in 2023 with a CAGR of 10.94% under the study period 2024-2032.

Red biotechnology, also known as medical biotechnology, is a branch of biotechnology focused on pharmaceuticals, medical devices, diagnostics, and healthcare solutions. Unlike green biotechnology (agricultural biotechnology) and white biotechnology (industrial biotechnology), it primarily targets medical and healthcare applications. It involves using biological processes, organisms, or systems to develop products and technologies to diagnose, prevent, and treat diseases and improve overall healthcare outcomes.

MARKET DYNAMICS

The global red biotechnology market is witnessing significant growth driven by the rising prevalence of chronic and infectious diseases worldwide. Red biotechnology is crucial in developing innovative therapies, vaccines, and diagnostic tools to address healthcare challenges associated with cancer, diabetes, cardiovascular disorders, and infectious diseases like COVID-19. Moreover, advancements in genomic research, personalized medicine, and biopharmaceuticals are fuelling market growth. Technologies such as gene editing, recombinant DNA technology, and monoclonal antibodies enable targeted and customized approaches to healthcare, enhancing treatment efficacy and patient outcomes.

Furthermore, increasing investments in research & development (R&D) by pharmaceutical companies, academic institutions, and government organizations drive innovation in red biotechnology. These investments support the discovery of novel drug candidates, biomarkers for disease diagnosis, and breakthrough therapies that leverage biotechnological advancements. Collaborations between academia, industry, and healthcare providers foster interdisciplinary research efforts to translate scientific discoveries into clinical applications. However, the high cost and lengthy development timelines associated with bringing biopharmaceuticals and medical innovations, regulatory challenges & stringent approval processes for biotechnological products pose a challenge to market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Red Biotechnology. The growth and trends of Red Biotechnology industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Red Biotechnology market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Monoclonal Antibodies
  • Polyclonal Antibodies
  • Recombinant Proteins
  • Vaccines
  • Cell-Based Immunotherapy Products
  • Gene Therapy Products
  • Cell Therapy Products
  • Tissue-Engineered Products
  • Stem Cells
  • Cell Culture
  • Viral Vector
  • Enzymes
  • Kits and Reagents
  • Animal models
  • Molecular diagnostics
  • Others

By End-User

  • Academic Research Institutes
  • CMOs & CROs
  • Pharmaceutical & Biotechnology Companies
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Red Biotechnology market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Red Biotechnology market include Merck KGaA, F. Hoffmann-La Roche AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., AstraZeneca Plc, Takeda Pharmaceutical Company Limited, Gilead Sciences, Biogen Inc., Amgen Inc., Celgene Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. RED BIOTECHNOLOGY - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By End-User
    • 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL RED BIOTECHNOLOGY MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data Analysis By Product
  • 5.3. Monoclonal Antibodies Historic and Forecast Sales By Regions
  • 5.4. Polyclonal Antibodies Historic and Forecast Sales By Regions
  • 5.5. Recombinant Proteins Historic and Forecast Sales By Regions
  • 5.6. Vaccines Historic and Forecast Sales By Regions
  • 5.7. Cell-Based Immunotherapy Products Historic and Forecast Sales By Regions
  • 5.8. Gene Therapy Products Historic and Forecast Sales By Regions
  • 5.9. Cell Therapy Products Historic and Forecast Sales By Regions
  • 5.10. Tissue-Engineered Products Historic and Forecast Sales By Regions
  • 5.11. Stem Cells Historic and Forecast Sales By Regions
  • 5.12. Cell Culture Historic and Forecast Sales By Regions
  • 5.13. Viral Vector Historic and Forecast Sales By Regions
  • 5.14. Enzymes Historic and Forecast Sales By Regions
  • 5.15. Kits and Reagents Historic and Forecast Sales By Regions
  • 5.16. Animal models Historic and Forecast Sales By Regions
  • 5.17. Molecular diagnostics Historic and Forecast Sales By Regions
  • 5.18. Others Historic and Forecast Sales By Regions

6. GLOBAL RED BIOTECHNOLOGY MARKET ANALYSIS BY END-USER

  • 6.1. Overview By End-User
  • 6.2. Historical and Forecast Data Analysis By End-User
  • 6.3. Academic Research Institutes Historic and Forecast Sales By Regions
  • 6.4. CMOs & CROs Historic and Forecast Sales By Regions
  • 6.5. Pharmaceutical & Biotechnology Companies Historic and Forecast Sales By Regions
  • 6.6. Others Historic and Forecast Sales By Regions

7. GLOBAL RED BIOTECHNOLOGY MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2 North America By Segment Sales Analysis
    • 7.3.3 North America By Country Sales Analysis
    • 7.3.4 United States Sales Analysis
    • 7.3.5 Canada Sales Analysis
    • 7.3.6 Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2 Europe By Segment Sales Analysis
    • 7.4.3 Europe By Country Sales Analysis
    • 7.4.4 United Kingdom Sales Analysis
    • 7.4.5 France Sales Analysis
    • 7.4.6 Germany Sales Analysis
    • 7.4.7 Italy Sales Analysis
    • 7.4.8 Russia Sales Analysis
    • 7.4.9 Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2 Asia Pacific By Segment Sales Analysis
    • 7.5.3 Asia Pacific By Country Sales Analysis
    • 7.5.4 China Sales Analysis
    • 7.5.5 India Sales Analysis
    • 7.5.6 Japan Sales Analysis
    • 7.5.7 South Korea Sales Analysis
    • 7.5.8 Australia Sales Analysis
    • 7.5.9 South East Asia Sales Analysis
    • 7.5.10 Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2 Latin America By Segment Sales Analysis
    • 7.6.3 Latin America By Country Sales Analysis
    • 7.6.4 Brazil Sales Analysis
    • 7.6.5 Argentina Sales Analysis
    • 7.6.6 Peru Sales Analysis
    • 7.6.7 Chile Sales Analysis
    • 7.6.8 Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2 Middle East & Africa By Segment Sales Analysis
    • 7.7.3 Middle East & Africa By Country Sales Analysis
    • 7.7.4 Saudi Arabia Sales Analysis
    • 7.7.5 UAE Sales Analysis
    • 7.7.6 Israel Sales Analysis
    • 7.7.7 South Africa Sales Analysis
    • 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE RED BIOTECHNOLOGY COMPANIES

  • 8.1. Red Biotechnology Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9. COMPANY PROFILES OF RED BIOTECHNOLOGY INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Merck KGaA
    • 9.3.1 Company Overview
    • 9.3.2 Company Revenue
    • 9.3.3 Products
    • 9.3.4 Recent Developments
  • 9.4. F. Hoffmann-La Roche AG
    • 9.4.1 Company Overview
    • 9.4.2 Company Revenue
    • 9.4.3 Products
    • 9.4.4 Recent Developments
  • 9.5. Pfizer Inc.
    • 9.5.1 Company Overview
    • 9.5.2 Company Revenue
    • 9.5.3 Products
    • 9.5.4 Recent Developments
  • 9.6. Regeneron Pharmaceuticals Inc.
    • 9.6.1 Company Overview
    • 9.6.2 Company Revenue
    • 9.6.3 Products
    • 9.6.4 Recent Developments
  • 9.7. AstraZeneca Plc
    • 9.7.1 Company Overview
    • 9.7.2 Company Revenue
    • 9.7.3 Products
    • 9.7.4 Recent Developments
  • 9.8. Takeda Pharmaceutical Company Limited
    • 9.8.1 Company Overview
    • 9.8.2 Company Revenue
    • 9.8.3 Products
    • 9.8.4 Recent Developments
  • 9.9. Gilead Sciences
    • 9.9.1 Company Overview
    • 9.9.2 Company Revenue
    • 9.9.3 Products
    • 9.9.4 Recent Developments
  • 9.10. Biogen Inc.
    • 9.10.1 Company Overview
    • 9.10.2 Company Revenue
    • 9.10.3 Products
    • 9.10.4 Recent Developments
  • 9.11. Amgen Inc.
    • 9.11.1 Company Overview
    • 9.11.2 Company Revenue
    • 9.11.3 Products
    • 9.11.4 Recent Developments
  • 9.12. Celgene Corporation
    • 9.12.1 Company Overview
    • 9.12.2 Company Revenue
    • 9.12.3 Products
    • 9.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product (USD MN)
  • Monoclonal Antibodies Market Sales By Geography (USD MN)
  • Polyclonal Antibodies Market Sales By Geography (USD MN)
  • Recombinant Proteins Market Sales By Geography (USD MN)
  • Vaccines Market Sales By Geography (USD MN)
  • Cell-Based Immunotherapy Products Market Sales By Geography (USD MN)
  • Gene Therapy Products Market Sales By Geography (USD MN)
  • Cell Therapy Products Market Sales By Geography (USD MN)
  • Tissue-Engineered Products Market Sales By Geography (USD MN)
  • Stem Cells Market Sales By Geography (USD MN)
  • Cell Culture Market Sales By Geography (USD MN)
  • Viral Vector Market Sales By Geography (USD MN)
  • Enzymes Market Sales By Geography (USD MN)
  • Kits and Reagents Market Sales By Geography (USD MN)
  • Animal models Market Sales By Geography (USD MN)
  • Molecular diagnostics Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By End-User (USD MN)
  • Academic Research Institutes Market Sales By Geography (USD MN)
  • CMOs & CROs Market Sales By Geography (USD MN)
  • Pharmaceutical & Biotechnology Companies Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Red Biotechnology Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Red Biotechnology Report
  • Market Research Process
  • Market Research Methodology
  • Global Red Biotechnology Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By End-User
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product (USD MN)
  • Monoclonal Antibodies Market Sales By Geography (USD MN)
  • Polyclonal Antibodies Market Sales By Geography (USD MN)
  • Recombinant Proteins Market Sales By Geography (USD MN)
  • Vaccines Market Sales By Geography (USD MN)
  • Cell-Based Immunotherapy Products Market Sales By Geography (USD MN)
  • Gene Therapy Products Market Sales By Geography (USD MN)
  • Cell Therapy Products Market Sales By Geography (USD MN)
  • Tissue-Engineered Products Market Sales By Geography (USD MN)
  • Stem Cells Market Sales By Geography (USD MN)
  • Cell Culture Market Sales By Geography (USD MN)
  • Viral Vector Market Sales By Geography (USD MN)
  • Enzymes Market Sales By Geography (USD MN)
  • Kits and Reagents Market Sales By Geography (USD MN)
  • Animal models Market Sales By Geography (USD MN)
  • Molecular diagnostics Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By End-User (USD MN)
  • Academic Research Institutes Market Sales By Geography (USD MN)
  • CMOs & CROs Market Sales By Geography (USD MN)
  • Pharmaceutical & Biotechnology Companies Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.